BD Secures CE Mark for Liverty TIPS Stent Graft to Advance Portal Hypertension Treatment in Europe
The next-generation adjustable stent graft expands treatment options for cirrhosis-related complications, with pivotal ARCH trial data set for presentation at SIR 2026.
BD And Company | 09/04/2026 | By News Bureau
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy